Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Market Data & B2B Solutions
Report a Bug
Market: Market:

Financial Technology & Market Data

 
No Matching Results
Advanced search
or
Menu

Trevena Inc (TRVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Go To:
Set Alerts
Watchlist
Is a Beat in the Cards for Vertex (VRTX) in Q3 Earnings? Zacks Equity Research - Zacks Investment Research - Fri Oct 20, 9:49AM CDT
Zacks Equity Research - ZACKS
Fri Oct 20, 9:49AM CDT

Vertex's (VRTX) Kalydeco is expected to generate increased revenues following its label expansion in the third quarter of 2017.

TRVN : 1.76 (+6.02%)
CELG : 121.33 (-10.76%)
VRTX : 154.63 (+0.02%)
CLVS : 77.50 (+0.95%)
Biotech Stocks on Investors' Radar -- Tesaro, Trevena, Omeros, and Radius Health PR Newswire - Fri Oct 13, 6:05AM CDT
CMTX
Fri Oct 13, 6:05AM CDT

If you want a Stock Review on TSRO, TRVN, OMER, or RDUS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Thursday, October 12, 2017, US markets saw...

TRVN : 1.76 (+6.02%)
RDUS : 35.64 (-0.94%)
TSRO : 116.40 (+0.77%)
OMER : 18.95 (-0.94%)
Trevena Announces Restructuring to Focus Resources on Commercial Strategy GlobeNewswire - Wed Oct 11, 3:01PM CDT
CMTX
Wed Oct 11, 3:01PM CDT

- Initiative streamlines operations to focus on approval and commercial launch of OLINVO(TM) (oliceridine injection) and significantly reduces operating expenses -

TRVN : 1.76 (+6.02%)
Trevena Announces Presentations during PAINWeek(R) 2017 GlobeNewswire - Thu Sep 7, 3:01PM CDT
CMTX
Thu Sep 7, 3:01PM CDT

- Hospital charge database study shows high prevalence of opioid-related adverse events in key surgical specialties despite use of multimodal analgesia -

TRVN : 1.76 (+6.02%)
Trevena to Present at the Rodman & Renshaw 19th Annual Global Investment Conference GlobeNewswire - Tue Sep 5, 3:01PM CDT
CMTX
Tue Sep 5, 3:01PM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the 19th Annual Global Investment Conference hosted by Rodman & Renshaw on Tuesday, September 12, 2017, at 12:05 p.m. EDT in New...

TRVN : 1.76 (+6.02%)
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Thu Aug 31, 3:01PM CDT
CMTX
Thu Aug 31, 3:01PM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of August 28, 2017, the grant of inducement stock...

TRVN : 1.76 (+6.02%)
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Mon Aug 14, 3:01PM CDT
CMTX
Mon Aug 14, 3:01PM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of July 31, August 7, and August 10, 2017, the grant...

TRVN : 1.76 (+6.02%)
Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma PR Newswire - Mon Aug 7, 5:10AM CDT
CMTX
Mon Aug 7, 5:10AM CDT

If you want a Stock Review on SRPT, TRVN, TSRO, or VRTX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has issued research...

TRVN : 1.76 (+6.02%)
SRPT : 51.94 (+2.41%)
VRTX : 154.63 (+0.02%)
TSRO : 116.40 (+0.77%)
Trevena Reports Second Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire - Thu Aug 3, 6:00AM CDT
CMTX
Thu Aug 3, 6:00AM CDT

- OLINVO program on track for NDA submission in September/October 2017 -

TRVN : 1.76 (+6.02%)
Trevena To Host 2017 Analyst Day and Announce Results of ATHENA Open Label Safety Study of OLINVO GlobeNewswire - Thu Jul 20, 11:11AM CDT
CMTX
Thu Jul 20, 11:11AM CDT

- Company now plans to submit its New Drug Application for OLINVO (oliceridine injection) in September or October 2017 -

TRVN : 1.76 (+6.02%)
Nabriva Therapeutics Appoints Carrie Bourdow and Colin Broom to the Board GlobeNewswire - Mon Jun 26, 7:00AM CDT
CMTX
Mon Jun 26, 7:00AM CDT

Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the...

TRVN : 1.76 (+6.02%)
NBRV : 6.33 (-4.67%)
Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications GlobeNewswire - Tue Jun 20, 3:01PM CDT
CMTX
Tue Jun 20, 3:01PM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the "Cutting Edge Science Meeting Series to End the Opioid Crisis: Development of Safe, Effective, Non-Addictive Pain Treatments"...

TRVN : 1.76 (+6.02%)
Breakfast Technical Briefing on Biotech Stocks -- Opko Health, Pain Therapeutics, Trevena, and Dynavax Technologies PR Newswire - Tue Jun 20, 5:10AM CDT
CMTX
Tue Jun 20, 5:10AM CDT

If you want a stock review on OPK, PTIE, TRVN, or DVAX then come over to http://dailystocktracker.com/register/ and sign up for your free customized reports today. This morning, DailyStockTracker.com turns...

TRVN : 1.76 (+6.02%)
PTIE : 3.84 (-5.42%)
DVAX : 20.40 (-2.16%)
OPK : 6.96 (+3.11%)
Trevena to Present at Investor Conferences in June GlobeNewswire - Fri Jun 2, 6:00AM CDT
CMTX
Fri Jun 2, 6:00AM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced that it will be attending the following investor conferences in June:

TRVN : 1.76 (+6.02%)
Trevena to Present at the Deutsche Bank Securities 42nd Annual Healthcare Conference GlobeNewswire - Wed Apr 26, 5:08PM CDT
CMTX
Wed Apr 26, 5:08PM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the 42 Annual Healthcare Conference hosted by Deutsche Bank Securities on Wednesday, May 3, 2017, at 2:50 p.m. EDT in Boston.

TRVN : 1.76 (+6.02%)
DB : 16.98 (+0.65%)
Trevena Announces Presentations at the 42nd Annual Regional Anesthesiology and Acute Pain Medicine Meeting GlobeNewswire - Thu Apr 6, 6:00AM CDT
CMTX
Thu Apr 6, 6:00AM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced the first scientific presentation of positive results from two Phase 3 pivotal efficacy studies of OLINVO(TM) (oliceridine injection), an investigational, next-generation...

TRVN : 1.76 (+6.02%)
Trevena to Present at Needham & Company's 16th Annual Healthcare Conference GlobeNewswire - Wed Mar 29, 3:01PM CDT
CMTX
Wed Mar 29, 3:01PM CDT

Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at Needham & Company's 16th Annual Healthcare Conference on Wednesday, April 5, 2017 at 10:00 a.m. EDT in New York.

TRVN : 1.76 (+6.02%)
Lifshitz & Miller LLP Announces Investigation of Argos Therapeutics, Inc., Avid Technology, Inc., HMS Holdings Corp., Invuity, Inc., SITO Mobile, Ltd., Trevena, Inc., USANA Health Sciences, Inc. and VAALCO Energy, Inc. PR Newswire - Fri Mar 24, 6:01PM CDT
CMTX
Fri Mar 24, 6:01PM CDT

Argos Therapeutics, Inc. (ARGS)

IVTY : 9.35 (+6.25%)
TRVN : 1.76 (+6.02%)
ARGS : 0.17 (unch)
USNA : 60.70 (+0.08%)
EGY : 0.74 (+1.37%)
HMSY : 19.36 (+0.94%)
AVID : 4.59 (+1.77%)
What Makes Trevena (TRVN) a Strong Sell? Zacks Equity Research - Zacks Investment Research - Wed Mar 22, 7:50AM CDT
Zacks Equity Research - ZACKS
Wed Mar 22, 7:50AM CDT

Trevena (TRVN) has witnessed a significant price decline in the past four weeks, and it has lately seen negative earnings estimate revisions as well.

TRVN : 1.76 (+6.02%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trevena, Inc. (TRVN) PR Newswire - Wed Mar 15, 11:04AM CDT
PRNW
Wed Mar 15, 11:04AM CDT

NEW YORK , March 15, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trevena, Inc. ("Trevena" or the...

TRVN : 1.76 (+6.02%)
Please wait...

Van Meerten Stock Picks

My 5 Favorite NASDAQ 100 Stocks
This morning I wanted to find the 5 best NASDAQ 100 stocks that had the highest return in the past year, had consistent price appreciation and still looked like they had room to go.
Thu Oct 19, 9:50AM CDT
AMAT +0.76 , NVDA -0.90 , ADSK +1.52 , MU +0.19 , LRCX +4.36
See More
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ17 +0.21%) this morning are up +0.23% at a new record high on optimism that the Trump administration will be able to enact its tax reform plans after the Senate adopted a fiscal 2018 budget... Read More
Fri Oct 20, 6:37AM CDT

Chart of the Day

Chart of the Day

LimeLight Networks (LLNW) is the Barchart Chart of the Day.  The Internet company has a Trend Spotter buy signal, a Weighted Alpha of 18.33+ and gained 149.71% in the last year.
Read More

Thu Oct 19, 10:37PM CDT

Brugler Ag Report

Today's Commentary

Corn futures ended Friday with most contracts 3 1/2 to 4 1/2 cents lower. The USDA announced private export sales of 125,000 MT of corn to Unknown Destinations, with an additional 120,000 MT to Spain for 17/18 delivery through their daily reporting s...
Read More

Fri Oct 20, 4:22PM CDT

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart